Brooks Laboratories share news, announcements and annual reports
NSE: BROOKSBSE: 533543Pharmaceuticals & BiotechnologySmall Cap
Brooks Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2011
Last close ₹60.56down ₹3.28 (5.14%)BSE ₹60.85
Share price at the NSE close on 30 Oct 2026. Previous close ₹63.84.
30 Oct: open ₹65.80, high ₹66.00, low ₹59.70
52-week range of traded prices to 30 Oct 2026
₹36.30Low, 30 Mar 2026₹116.00High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹178 Cr2,450th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.50
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.45
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 54,79557.7% delivered
Brooks Laboratories board meetings
108 filed, newest first. Page 2 of 3.
Apr 2020
12 Apr · Board meeting
Mar 2020
19 Mar · Board meeting
2 Mar · Board meeting
Feb 2020
14 Feb · Board meeting
7 Feb · Board meeting
6 Feb · Board meeting
Jan 2020
23 Jan · Board meeting
Nov 2019
Jun 2019
11 Jun · Board meeting
3 Jun · Board meeting
May 2019
21 May · Board meeting
Feb 2019
6 Feb · Board meeting
Nov 2018
Aug 2018
6 Aug · Board meeting
Jul 2018
11 Jul · Board meeting
3 Jul · Board meeting
May 2018
Feb 2018
Dec 2017
Sep 2017
May 2017
Feb 2017
Nov 2016
Aug 2016
May 2016
Feb 2016
Oct 2015
Aug 2015
May 2015
Feb 2015
3 Feb · Board meeting
To consider and to approve, inter alia, Unaudited Financial Results for the quarter and nine months ended 31st December, 2014.
Oct 2014
29 Oct · Board meeting
To consider and to approve, inter alia, Unaudited Financial Results for the quarter and half year ended 30th September, 2014.
Aug 2014
13 Aug · Board meeting
Appointment of Mr. Ankit Parekh as the Company Secretary Cum Compliance Officer of the Company w.e.f. August 01st,2014.
May 2014
Feb 2014
Nov 2013
Aug 2013
May 2013
20 May · Board meeting
To consider and to approve, inter alia, Audited Financial Results for the quarter and financial year ended March 31, 2013.
Feb 2013
4 Feb · Board meeting
To consider and to approve, inter alia, unaudited Financial Results for the quarter ended December 31, 2012
Oct 2012
31 Oct · Board meeting
To transact the following business : (1) To consider and to approve unaudited Financial Results for the quarter and half-year ended September 30, 2012; and (2) To transact any other business.
Aug 2012
23 Aug · Board meeting
To transact the following businesses : (1) To approve the Annual Report of the Company carrying its Directors' Report, Management Discussion and Analysis and Cooperate Governance Report for the F.Y. 2011-12; (2) To issue Notice of forthcoming Annual General Meeting; (3) Any other business.6 Aug · Board meeting
To transact the following business : (1) To consider and to approve un-audited Financial Results for the quarter ended June 30, 2012; and (2) To transact any other business.
Jun 2012
29 Jun · Board meeting
Meeting of the Board of Directors of the Company was held on June 28, 2012, wherein the following resolutions were passed unanimously: (1) To consider and approve the appointment of Mr. Anil Khanna as Additional Independent Director with immediate effect. (2) To consider and approve the re-appointment of Cost Auditor.
May 2012
23 May · Board meeting
18 May · Board meeting
To transact the following business : (1) To consider and to approve audited Financial Results for the year ended March 31, 2012; and (2) To transact other routine businesses.
Feb 2012
17 Feb · Board meeting
Board of Directors of the Company in their meeting held on February 15, 2012 discussed and decided the following matters: (1) Accepted the resignation of Company Secretary cum Compliance Officer of the Company w.e.f. February 06, 2012.8 Feb · Board meeting
To discuss and approve the unaudited provisional results for quarter ended December 31, 2011.
Jan 2012
30 Jan · Board meeting
Board of Directors of the Company in their meeting held on January 28, 2012, accept the resignation of below mentioned Directors w.e.f. January 06, 2012: (1) Vivek Sharma. (2) Lalit Mahajan. (3) Monika Sabharwal.25 Jan · Board meeting
To accept the resignation of Independent directors of the Company.